Suchergebnisse - "Liu, Rachael"

PubPharm (5)

1

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma : a detailed analysis from the phase III ECHELON-1 study

enthalten in: Haematologica | 2022

von Evens, A. | Connors, J. | Younes, A. | +16

2

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1) : 5-year update of an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2021

von Straus, D. | Długosz-Danecka, M. | Connors, J. | +24

CommentIn: Lancet Haematol. 2021 Jun;8(6):e384-e386. - PMID 34048674

3

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma : A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study

enthalten in: Hematological oncology | 2021

von Hutchings, M. | Radford, J. | Ansell, S. | +17

4

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma : 3-year update of the ECHELON-1 study

enthalten in: Blood | 2020

von Straus, D. | Długosz-Danecka, M. | Alekseev, S. | +23

CommentIn: Blood. 2020 Mar 5;135(10):704-706. - PMID 32135016

5

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

enthalten in: The New England journal of medicine | 2018

von Connors, J. | Jurczak, W. | Straus, D. | +127

CommentIn: N Engl J Med. 2018 Jan 25;378(4):392-394. - PMID 29224505

1
[1]